CannBioRx Life Sciences Corp. (ATNFW)

USD 0.01

(6.94%)

Total Assets Summary of CannBioRx Life Sciences Corp.

CannBioRx Life Sciences Corp.'s latest annual total assets in 2023 was 5.25 Million USD , down -73.23% from previous year.
CannBioRx Life Sciences Corp.'s latest quarterly total assets in 2024 Q1 was 3.44 Million USD , down -34.56% from previous quarter.
CannBioRx Life Sciences Corp. reported annual total assets of 19.65 Million USD in 2022, down -68.67% from previous year.
CannBioRx Life Sciences Corp. reported annual total assets of 62.71 Million USD in 2021, up 12.93% from previous year.
CannBioRx Life Sciences Corp. reported quarterly total assets of 3.44 Million USD for 2024 Q1, down -34.56% from previous quarter.
CannBioRx Life Sciences Corp. reported quarterly total assets of 5.25 Million USD for 2023 FY, down -73.23% from previous quarter.

Annual Total Assets Chart of CannBioRx Life Sciences Corp. (2023 - 2017)

Historical Annual Total Assets of CannBioRx Life Sciences Corp. (2023 - 2017)

Year	Total Assets	Total Assets Growth
2023	5.25 Million USD	-73.23%
2022	19.65 Million USD	-68.67%
2021	62.71 Million USD	12.93%
2020	55.53 Million USD	7.03%
2019	51.88 Million USD	3455.64%
2018	1.45 Million USD	-98.75%
2017	117.05 Million USD	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	3.91 Million USD	13.65%
2024 Q1	3.44 Million USD	-34.56%
2023 FY	5.25 Million USD	-73.23%
2023 Q2	13.66 Million USD	-8.41%
2023 Q1	14.92 Million USD	-24.06%
2023 Q3	4.95 Million USD	-63.72%
2023 Q4	5.25 Million USD	6.08%
2022 Q3	34.33 Million USD	-35.65%
2022 Q4	19.65 Million USD	-42.77%
2022 Q2	53.35 Million USD	-10.59%
2022 Q1	59.67 Million USD	-4.84%
2022 FY	19.65 Million USD	-68.67%
2021 FY	62.71 Million USD	12.93%
2021 Q1	60.11 Million USD	8.25%
2021 Q2	56.26 Million USD	-6.4%
2021 Q3	65.06 Million USD	15.65%
2021 Q4	62.71 Million USD	-3.62%
2020 Q4	55.53 Million USD	403.73%
2020 Q3	11.02 Million USD	-78.11%
2020 Q2	50.37 Million USD	307.28%
2020 Q1	12.36 Million USD	-76.16%
2020 FY	55.53 Million USD	7.03%
2019 FY	51.88 Million USD	3455.64%
2019 Q4	51.88 Million USD	0.83%
2019 Q3	51.45 Million USD	5340.03%
2019 Q2	945.91 Thousand USD	-98.58%
2019 Q1	66.47 Million USD	4455.29%
2018 Q1	117.3 Million USD	0.21%
2018 FY	1.45 Million USD	-98.75%
2018 Q4	1.45 Million USD	-98.77%
2018 Q3	118.22 Million USD	0.23%
2018 Q2	117.95 Million USD	0.55%
2017 FY	117.05 Million USD	0.0%
2017 Q2	116.81 Million USD	0.0%
2017 Q3	117.02 Million USD	0.18%
2017 Q4	117.05 Million USD	0.03%

Peer Total Assets Comparison of CannBioRx Life Sciences Corp.

Name	Total Assets	Total Assets Difference
BIMI International Medical Inc.	35.71 Million USD	85.274%
China Jo-Jo Drugstores, Inc.	95.05 Million USD	94.467%
Harrow Health, Inc. 8.625% Senior Notes due 2026	311.75 Million USD	98.313%
Harrow Health, Inc. 11.875% Senior Notes due 2027	312.16 Million USD	98.315%
Leafly Holdings, Inc.	21.83 Million USD	75.913%
Leafly Holdings, Inc.	21.83 Million USD	75.913%
LifeMD, Inc.	58.48 Million USD	91.006%
LifeMD, Inc.	58.48 Million USD	91.006%
TRxADE HEALTH, Inc.	12.53 Million USD	58.035%
PetMed Express, Inc.	175.09 Million USD	96.996%
Walgreens Boots Alliance, Inc.	81.03 Billion USD	99.994%